Antiplatelet Agents Utilization Pattern and Assessment of Patient Specific Drug use Problems among Cardiac Patient

Hadia, Rajesh and Shah, Priyanshi and John, Johncy Mariam and Patel, Rutvi and Gohel, Kushal kumar and Mathew, Cinosh and Rathod, Trupal and Joshi, Dhaval and Maheshwari, Rajesh (2021) Antiplatelet Agents Utilization Pattern and Assessment of Patient Specific Drug use Problems among Cardiac Patient. Journal of Pharmaceutical Research International, 33 (33B). pp. 6-12. ISSN 2456-9119

[thumbnail of 2620-Article Text-4297-1-10-20221006.pdf] Text
2620-Article Text-4297-1-10-20221006.pdf - Published Version

Download (193kB)

Abstract

Background: Antiplatelet agents reduce the occurrence of the cardiovascular issue in people with established cardiovascular disease.

Objective: To understand the pattern of Antiplatelet drug utilization among cardiovascular disease patients. To evaluate the prevalence of polypharmacy and responsible factors like age, gender, co-morbid condition, and patient-related drug use problems.

Methodology: A cross-sectional observational study. Patients with cardiovascular disease above 18 years of age were prescribed antiplatelet agents from the department of cardiology and ICCU were enrolled in the study.

Result: A total of 150 patients were enrolled of which male 79% (N=119) and female 21% (N=31). Most patients belong to 51-60 years of age groups. The patients diagnosed with IWMI (inferior wall myocardial infarction) 43.3% (N=65) have highly prescribed antiplatelet agents. Smoking 54.7% (N=82) followed by Alcohol 26.7% (N=40) found to be the most dominant risk factors.60.7% (N=91) patients had no comorbidity followed by 31.3% (N=47) had a comorbid cardiac condition. Most prescribed antiplatelet agents were monotherapy of Aspirin 28.8% (N=43), Clopidogrel 16.7% (N=25), and combination therapy of both 51.2% (N=82).

Conclusion: The study concluded that increases in the number of co-morbidities can significantly increase the Utilization of drugs which can further lead to drug use problems. The clinical pharmacist can help to alleviate the problems of polypharmacy and its consequence.

Item Type: Article
Subjects: Journal Eprints > Medical Science
Depositing User: Managing Editor
Date Deposited: 28 Feb 2023 09:24
Last Modified: 06 Mar 2024 04:13
URI: http://repository.journal4submission.com/id/eprint/997

Actions (login required)

View Item
View Item